Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ReposiTrak (TRAK) EBT (2016 - 2025)

ReposiTrak has reported EBT over the past 16 years, most recently at $2.1 million for Q4 2025.

  • Quarterly results put EBT at $2.1 million for Q4 2025, up 25.41% from a year ago — trailing twelve months through Dec 2025 was $8.5 million (up 25.48% YoY), and the annual figure for FY2025 was $7.7 million, up 20.86%.
  • EBT for Q4 2025 was $2.1 million at ReposiTrak, down from $2.3 million in the prior quarter.
  • Over the last five years, EBT for TRAK hit a ceiling of $2.3 million in Q3 2025 and a floor of $783152.0 in Q1 2021.
  • Median EBT over the past 5 years was $1.5 million (2023), compared with a mean of $1.5 million.
  • Peak annual rise in EBT hit 186.82% in 2021, while the deepest fall reached 43.29% in 2021.
  • ReposiTrak's EBT stood at $927343.0 in 2021, then surged by 42.92% to $1.3 million in 2022, then grew by 18.1% to $1.6 million in 2023, then grew by 8.82% to $1.7 million in 2024, then rose by 25.41% to $2.1 million in 2025.
  • The last three reported values for EBT were $2.1 million (Q4 2025), $2.3 million (Q3 2025), and $2.0 million (Q2 2025) per Business Quant data.